Liver Scores in the Prognostication of COVID-19 Patients

Liver Scores in the Prognostication of COVID-19 Patients

The implementation of easily accessible prognostic biomarkers for patients with COVID-19 remains an important area of clinical research. In this large monocentric study at a German tertiary care hospital, we determined the prognostic performance of different liver scores in 605 patients with COVID-1...

Full description

Saved in:

Bibliographic Details
Main Authors:	Thilo Gambichler, Dominic König, Nadine Schuleit, Laura Susok, Wolfgang Schmidt, Nessr Abu Rached
Format:	Article
Language:	English
Published:	MDPI AG 2025-03-01
Series:	Viruses
Subjects:	SARS-CoV-2 hepatitis systemic immune-inflammation hepatic insufficiency fibrosis coagulation
Online Access:	https://www.mdpi.com/1999-4915/17/3/444
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hepatitis B associated with severe COVID-19: a nationwide cohort study in Sweden
by: Frida Jakobsson, et al.
Published: (2025-04-01)

A systematic review on nutraceuticals as a potential source of therapeutics against COVID-19 and other emerging viral diseases
by: Pankaj Singh, et al.
Published: (2025-07-01)

Hepatitis B virus associated with severe acute respiratory syndrome coronavirus 2 infection: a case report
by: Carmen-Elena Florea, et al.
Published: (2025-02-01)

Effect of Allostatic Load on hepatic steatosis and fatty liver-associated liver fibrosis
by: Lei Zhang, et al.
Published: (2025-07-01)

Presence of liver fibrosis in chronic hepatitis B patients with varying serum hepatitis B virus DNA levels: Letter to the editor on “Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B”
by: Jian Wang, et al.
Published: (2025-01-01)

NEW APPROACHES TO STUDIES OF IMMUNOLOGICAL IMBALANCE IN LIVER INSUFFICIENCY
by: A. N. Plekhanov, et al.
Published: (2014-07-01)

MODERN METHODS FOR ESTIMATION OF LIVER FIBROSIS
by: E. V. Guschina, et al.
Published: (2015-08-01)

Study on SARS-CoV-2 infection in middle-aged and elderly population infected with hepatitis virus: a cohort study in a rural area of northeast China
by: Yuchen Pan, et al.
Published: (2025-02-01)

The Associations of Serum Folate Forms with Metabolic Dysfunction-Associated Fatty Liver Disease and Liver Fibrosis: A Nationwide Cross-Sectional Study
by: Hai Zhao, et al.
Published: (2025-06-01)

Clinical Characteristics and Outcomes in Patients with Chronic HBV Infection and Hospitalized for COVID-19 Pneumonia: A Retrospective Cohort Study
by: Lucio Boglione, et al.
Published: (2024-12-01)

De Ritis Ratio Is a Potential Independent Predictor of Recurrence of Single-Organ Cutaneous Small Vessel Vasculitis
by: Thilo Gambichler, et al.
Published: (2025-05-01)

Morphogenesis of pericellular liver fibrosis in patients with chronic viral hepatitis C associated with hepatic steatosis
by: V. A. Tumanskiy, et al.
Published: (2012-08-01)

Prognostic model of rapid hepatic fibrosis progression in men with chronic hepatitis C
by: T. I. Koval, et al.
Published: (2019-05-01)

Association between the lymphocyte-to-high-density lipoprotein ratio and metabolic dysfunction-associated steatotic liver disease among US adults: a cross-sectional study from NHANES 2017 to 2020
by: Chuanzhi Tang, et al.
Published: (2024-12-01)

Morphological and ultrasound features of liver fibrosis in children with autoimmune hepatitis
by: V. S. Berezenko, et al.
Published: (2018-12-01)

Prognostic Implications of Initial Radiological Findings of Pulmonary Fibrosis in Patients with Acute SARS-CoV-2 Infection: A Prospective Multicentric Study
by: Roxana-Elena Cîrjaliu, et al.
Published: (2024-11-01)

Correlation of SARS-CoV-2 Infection with Hepatitis and Liver Disorders
by: Kimia Kardani, et al.
Published: (2021-09-01)

Diagnostic accuracy of FibroScan-AST (FAST) score, non-alcoholic fatty liver fibrosis score (NFS), FibroScan, and liver fibrosis index (FIB-4) for identifying fibrotic non-alcoholic steatohepatitis in patients with chronic hepatitis B with metabolic dysfunction-associated fatty liver disease
by: Youwen Tan, et al.
Published: (2024-12-01)

Enhancing liver fibrosis detection: a novel PIGR-utilizing approach in chronic hepatitis B injury assessment
by: Shanshan Chu, et al.
Published: (2025-02-01)

Association of alpha-1 acid glycoprotein with hepatic steatosis and liver fibrosis among women: a population-based study
by: Sichang Wang
Published: (2025-08-01)

Relationship of tea consumption with hepatic steatosis and fibrosis: findings from a longitudinal RaNCD cohort
by: Shaimaa A. Qaisar, et al.
Published: (2025-03-01)

Clinical, laboratory and coagulation system of blood feachers in patients with viral liver cirrhoses associated with virus hepatitis B, C and D
by: S. A. Bogushevich, et al.
Published: (2009-08-01)

Whole-cell response of coronavirus-infected BMDCs through proteomic and transcriptomic analyses
by: Yanxi Ji, et al.
Published: (2025-06-01)

Ethanol with thioacetamide murine model of alcoholic liver disease identifies hepatic pathways as targets for the human disease
by: Ashi Mittal, et al.
Published: (2025-01-01)

Dynamic crosstalk between HSCs and liver microenvironment: multicellular interactions in the regulation of liver fibrosis
by: Luping Wang, et al.
Published: (2025-07-01)

Comparative evaluation of APRI and MELD scores in the prediction of complications of chronic hepatitis in patients infected with hepatitis B or C viruses in Lubumbashi, democratic republic of Congo
by: Arsène Kabamba-Tshikongo, et al.
Published: (2025-02-01)

DIABETES MELLITUS IN PATIENTS WITH LIVER CIRRHOSIS: NEW TREATMENT OPTIONS
by: L. Yu. Morgunov
Published: (2017-09-01)

Correspondence to letter to the editor on “Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B”
by: Gi-Ae Kim, et al.
Published: (2025-01-01)

SARS‐CoV‐2 placentitis and severe pregnancy outcome after maternal infection: A Danish case series
by: Stine Y. Nielsen, et al.
Published: (2023-05-01)

Cerebral hemodynamic and metabolic changes in fulminant hepatic failure
by: Fernando Mendes Paschoal Junior, et al.

Experimental Liver Surgery for Liver Research: Update, Choice and Translation
by: Shi JH, et al.
Published: (2025-03-01)

Noninvasive assessment of nonalcoholic fatty liver disease
by: Gajanan A Rodge, et al.
Published: (2021-01-01)

Magnoflorine ameliorates hepatic fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway
by: Meiling Zhang, et al.
Published: (2024-11-01)

Differential effects of systemic immune inflammation indices on hepatic steatosis and hepatic fibrosis: evidence from NHANES 1999–2018
by: Shuyin Duan, et al.
Published: (2024-12-01)

The diagnostic value of indirect markers of liver fibrosis in patients with chronic hepatitis B
by: D. V. Tereshkov, et al.
Published: (2020-03-01)

The validity of serum autotaxin as a predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease
by: Muhammad Abdel-Gawad, et al.
Published: (2023-10-01)

Therapeutic Potential of PDA@CeO2 in Suppressing Hepatic Stellate Cell Activation and Preventing Liver Fibrosis
by: Li HM, et al.
Published: (2025-07-01)

VIRAL CIRRHOSIS: AN OVERVIEW OF HAEMOSTATIC ALTERATIONS AND CLINICAL CONSEQUENCES
by: Francesca Romana Ponziani, et al.
Published: (2009-12-01)

VIRAL CIRRHOSIS: AN OVERVIEW OF HAEMOSTATIC ALTERATIONS AND CLINICAL CONSEQUENCES
by: Antonio Gasbarrini, et al.
Published: (2009-11-01)

Retinoic acids and nuclear receptor signaling in liver development: Pathogenic roles in liver diseases
by: Wen Jia, et al.
Published: (2024-03-01)